More Than a Quarter of Americans Admitted Exaggerating Symptoms to Seek Antibiotics
A new study in JAMA Network Open puts a hard number on a familiar problem in outpatient medicine: more than a quarter of Americans said they had exaggerated or invented symptoms to try to get antibiotics from a clinician. The behavior is not just a matter of patient dishonesty. It reflects how deeply entrenched the belief remains that antibiotics are the answer whenever an illness feels severe, prolonged, or disruptive to daily life.
The finding matters because antibiotic prescribing is not driven only by clinical need. It is also shaped by patient expectations, time pressure in busy practices, and the persistent mismatch between what people think a drug can do and what it can actually treat. Antibiotics work against bacterial infections, not viral syndromes, inflammatory self-limited illnesses, or the majority of upper respiratory complaints that bring patients to a clinic in the first place.
One sentence captures the problem plainly: people often seek antibiotics because they feel very sick, even when the medication is unlikely to help.
That gap between perceived severity and appropriate treatment is where misuse begins.
The study found that respondents who misrepresented symptoms were often motivated by the belief that antibiotics were the only treatment that would work. In bedside terms, that is a dangerous form of therapeutic certainty. A patient with fever, congestion, cough, sore throat, or sinus pressure may feel profoundly unwell, yet those symptoms alone do not establish a bacterial infection. When antibiotics are handed out in that setting, they can reinforce the false idea that symptom relief depends on receiving a prescription rather than on careful diagnosis, supportive care, or watchful waiting.
The downstream effects are well known even if they are easy to ignore in a rushed visit. Unnecessary antibiotic exposure contributes to antimicrobial resistance, which erodes the effectiveness of these drugs for the patients who truly need them. It also exposes individuals to avoidable adverse effects, including gastrointestinal intolerance, allergic reactions, and the broader ecological harm that comes from repeated antibiotic pressure on the human microbiome. None of that is theoretical. Every unnecessary prescription adds a small but real increment to a larger public health problem.
Prescribing pressure also creates a clinical trap for physicians and advanced practice clinicians. When patients arrive already convinced that antibiotics are necessary, the conversation can become less about diagnosis and more about negotiation. That dynamic is especially difficult in pediatrics and family medicine, where parents and caregivers may feel forced to advocate aggressively if a child seems miserable. For clinicians, the task is to distinguish infection from inflammation, severity from bacterial disease, and anxiety from indication. For patients, the task is harder still: tolerating uncertainty when a quick pharmacologic fix is unavailable.
The study’s broader message is about demand as much as supply. Overprescribing is often discussed as a clinician behavior problem, but this finding shows that patient beliefs help sustain it. If more than one-quarter of Americans admit to false or exaggerated claims in hopes of getting antibiotics, the appetite for these drugs is not confined to exam room habit or physician caution. It is embedded in the culture of illness itself.
Public health strategies have to respond to that reality. Education cannot be limited to telling patients that antibiotics do not treat viruses. It has to explain why clinicians sometimes withhold them despite significant symptoms, why delayed prescriptions can be safer than immediate ones in selected cases, and why symptom relief does not always require an antimicrobial. Communication matters because patients are making decisions based on what they believe will happen if they leave without a prescription. When the message is weak, they may push harder at the visit or seek care elsewhere until they find a prescriber willing to comply.
The findings also fit a larger pattern seen across health care: when people think a treatment is the only path to relief, they will sometimes reshape the story of their illness to fit the treatment. In this case, that behavior lands directly on one of medicine’s most fragile resources—effective antibiotics. The pressure does not just affect a single encounter. It accumulates across communities, clinics, and years of use.
Because the study was framed as a survey of self-reported behavior, it captures attitudes and admissions rather than direct prescribing outcomes. Even so, the signal is clear enough to matter clinically. Patient demand remains a powerful force in antibiotic use, and that pressure begins long before a prescription is written. A clinician may hear one complaint in the room, while a much larger set of expectations is operating in the background.
The practical question is how to reduce that pressure without turning every visit into a standoff. Better communication, clearer education about bacterial versus viral illness, and more explicit counseling about what antibiotics can and cannot do are all part of the answer. So is a culture in which clinicians feel supported when they decline an unnecessary prescription and patients are taught that not every serious-feeling illness is antibiotic-responsive.
What the study exposes is not a rare misuse pattern but a routine feature of outpatient care. The challenge now is whether health systems can change the expectations that keep it in place, because every false antibiotic request is another reminder that the problem starts before the prescription pad comes out.